Australia Healthcare, Regulatory and Reimbursement Landscape 2019 -

DUBLIN--()--The "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia" report has been added to's offering.

It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Australia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

Australia has one of the fastest growing pharmaceutical markets in the world, providing safe and affordable health care to its citizen. The pharmaceutical market in Australia was valued at $10.58B in 2011 and increased at CAGR of 3.3% to $11.69B in 2018. The market is expected to reach $13.33B in 2022. However, the market value in terms of Australian Dollar was AUD$10.26B in 2011 and increased at a CAGR of 6% to AUD$15.65B in 2018. It is expected to reach AUD$19.78B in 2022.

In 2015, the medical device market in Australia was worth $8.4B, which increased to $9.5B in 2018 at a CAGR of 4.2%. It is expected to reach $11.9B in 2023. The Australian healthcare market is driven by universal healthcare coverage, wide access to government-subsidized medicine, growing elderly population and its associated disease burden, well-defined regulatory guidelines, the usage of substitute drugs and the introduction of a new manufacturing policy.


  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, Pfizer, Astrazeneca, GSK, and Clinuvel) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Siemens, Stryker, and Zimmer Biomet)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Australia
  • Porter's five forces analysis for pharmaceutical and medical devices market of Australia
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding the health-tech landscape of the country along with the major health-tech deals
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Australian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving the Australian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Australian healthcare market

Key Topics Covered:

1 Executive Summary

1.1 Executive Summary - Overview

1.2 Key Highlights

1.3 Key Highlights: Australian Government and Healthcare Initiatives, 2019

1.4 Key Highlights: Healthcare Startups in Australia

1.5 Key Events: Australia Healthcare Services History, 2011-2018

1.6 Key Events: Australia Pharmaceutical Market

1.7 Key Events: Australia Healthcare Deals History, 2014-2019

1.8 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019

1.9 Key Events: Mergers and Acquisitions

1.10 Country Profile, Australia, 2019

2 Overview of Pharmaceutical Market

2.1 Pharmaceutical Market - Overview

2.2 Pharmaceutical Market - Exports

2.3 Pharmaceutical Market - Imports

2.4 Pharmaceutical Market - Supply Channels

2.5 Pharmaceutical Market - Market Segments

2.6 Pharmaceutical Market - Major Therapeutic Areas

2.7 Pharmaceutical Market - Major Players

3 Overview of Medical Devices Market

3.1 Medical Device Market - Overview

3.2 Medical Device Market - Top Five Segments

3.3 Medical Device Market - Diagnostic Market

3.4 Medical Device Market - Major Players

4 Pharmaceutical and Medical Device Market - Drivers and Barriers

4.1 Drivers

4.2 Barriers

5 Deal analysis

5.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Australia

5.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Australia

6 Pharmaceutical and Medical Device Market - Porter's Five Forces Analysis

6.1 Pharmaceutical Market, Australia - Porter's Five Forces Analysis

6.2 Medical Device Market, Australia - Porter's Five Forces Analysis

7 Market Access

7.1 Overview of Healthcare System, Australia

7.2 Reimbursement Process, Australia

7.2.1 Reimbursement Process for Pharmaceutical Products, Australia

7.2.2 Reimbursement Process for Medical Devices Products, Australia

7.2.3 Overview of Insurance Providers, Public Health Insurance, Australia

7.2.4 Overview of Insurance Providers, Private Health Insurance, Australia

7.2.5 Healthcare Spending and Price Trends in the Healthcare Sector, Australia

7.2.6 Pricing Policies, Australia

7.3 Regulatory Landscape, Australia

7.3.1 Market Authorization for Pharmaceutical Products, Australia

7.3.2 Market Authorization for Medical Devices, Australia

7.3.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing, Australia

7.3.4 Licensing Process for Pharmaceutical Exports and Imports, Australia

7.3.5 Intellectual Property Rights, Patent, Australia

7.3.6 Intellectual Property Rights, Trademark, Australia

7.3.7 Pharmaceutical Clinical Trials Landscape, Australia

7.3.8 Medical Devices Clinical Trials Landscape, Australia

7.3.9 Clinical Trial Regulation Process, Australia

7.3.10 Pharmaceutical Advertising Regulations, Australia

7.3.11 Pharmacy Regulation, Australia

7.3.12 Labeling and Packaging Regulations, Australia

8 HealthTech Landscape

8.1 HealthTech Deals Landscape, Australia

8.2 Key HealthTech Deals, Australia

8.3 Adoption of Technology in Healthcare, Australia

8.4 Regulatory Scenario Covering Use of Technology in Healthcare

8.5 HealthTech Landscape- Australia- Benefits and Risks

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Life Expectancy and Immunization Rate

9.5 Environmental Health

9.6 Healthcare Personnel

9.7 Disease Burden

9.8 Healthcare Expenditure

9.8.1 Healthcare Expenditure - Overview

9.8.2 Share of Public and Private Sectors

10 Trade Associations

11 Trade Fairs, Australia

12 Opportunities and Challenges

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900